European Commission Approves MGC Derma Cosmetics Products
Filed with ASX · · 2 pages · English
Earlier from Argent Biopharma
- ASX Approval of Panax Transaction and Capital Raising Update
- MXC to Raise $5.0m - Capital Raising Oversubscribed
- MXC to Acquire Licensed European Medical Cannabis Company
- Response to ASX Price Query
- MXC to Enter Australian Medicinal Cannabis Market
Later from Argent Biopharma
- Supplementary Prospectus
- Priority Offer Timetable - Update
- Prospectus - Priority Offer
- Shareholder Priority Offer Closed Early - Oversubscribed
- FDA Approval Granted and First US Distribution Deal Signed
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma